Research Article
Volume 17 Issue 1 - 2021
Ocular Findings of Patients with Coronavirus Disease 2019 (COVID-19): A Literature Review
Amna Saeed Fallata1*, Rawan Eid Alatawi2, Lujain Hamid Mustafa3, Rawan Khalid Aloteebi4, Faisal Abdullah Alamri5, Sultan Musallam Alshammari4, Leena Khalid Koshak6, Sultan Abdulrahman Alyali5, Futoon Jomman Alomari7, Nawaf Mesaad Bahatheq8 and Abdulelah Tarek BinYamin9
1Consultant of Ophthalmology, Dr. Amna S. Fallata Specialist Clinic in Ophthalmology, Mecca, Saudi Arabia
2College of Medicine, King Saud Bin Abdulaziz University For Health Science, Riyadh, Saudi Arabia
3College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
4College of Medicine, Almaarefa University, Riyadh, Saudi Arabia
5College of Medicine, King Khalid University, Abha, Saudi Arabia
6Department of Ophthalmology, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia
7College of Medicine, Jordan University of Science and Technology, Irbid, Jordan
8Department of Dermatology, Al-Iman General Hospital, Riyadh, Saudi Arabia
9College of Medicine, Ibn Sina National College fo rMedical Studies, Jeddah, Saudi Arabia
*Corresponding Author: Sumya Hassan Daws, King Abdulaziz Hospital and Oncology Center, Jeddah, Saudi Arabia
Received: November 25, 2020; Published: December 30, 2020




Abstract

Background: COVID-19 pandemic has many clinical presentations not related to respiratory symptoms. Ocular symptoms are reported in many cases and conjunctivitis is now considered as one of the well-established symptoms in COVID-19 patients. However, the ocular pathologies in COVID-19 patients are not well studied. In this study, we reviewed the literature to stand on the epidemiology and clinical presentation of ocular pathologies in COVID-19 patients.

Methods: We searched the MEDLINE database using PubMed. Two independent reviewers reviewed the resulting papers and reviewed them based on our inclusion criteria.

Results: Based on the review results, many studies reported the presence of viral DNA in tears and conjunctival swabs. These studies implied a conjunctival route of infection to the respiratory system. The presence of ocular symptoms indicated a worse prognosis. The most common reported ocular diseases were conjunctivitis and ocular surface diseases. However, there is still no clear and proved evidence of the pathogenesis of these diseases.

Conclusion: The exact epidemiology and pathogenesis of the ocular diseases in COVID-19 patients is not clear and was not investigated thoroughly in the recent literature. However, many reports indicated the high prevalence of conjunctivitis and ocular surface infection in these patients. More studies are needed to identify the underlying pathogenesis of ocular diseases.

Keywords: COVID-19; SARS-COV-2; Conjunctivitis; Retinitis; Ocular Diseases; Eye Infection

References

  1. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China] 0254-6450.
  2. Masters PSBTAiVR. “The Molecular Biology of Coronaviruses”. 66: Academic Press (2006): 193-292.
  3. Perlman S and Netland J. “Coronaviruses post-SARS: update on replication and pathogenesis”. Nature Reviews Microbiology6 (2009): 439-450.
  4. Lu CW., et al. “2019-nCoV transmission through the ocular surface must not be ignored”. Lancet10224 (2020): e39.
  5. Ma D., et al. “Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea”. Eye7 (2020): 1212-1219.
  6. Zhou L., et al. “ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection”. The Ocular Surface4 (2020): 537-544.
  7. Chen L., et al. “Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study”. Acta Ophthalmologica (2020): 81974136.
  8. Chen L., et al. “Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease”. The British Journal of Ophthalmology 6 (2020): 748-751.
  9. Sun X., et al. “The infection evidence of SARS-COV-2 in ocular surface a single-center cross-sectional study (2020): 8197033356.
  10. Wu P., et al. “Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China”. JAMA Ophthalmology 5 (2020): 575-578.
  11. Zhou Y., et al. “Ocular Findings and Proportion with Conjunctival SARS-COV-2 in COVID-19 Patients”. Ophthalmology7 (2020): 982-983.
  12. Guan W-J., et al. “Clinical Characteristics of Coronavirus Disease 2019 in China”. The New England Journal of Medicine18 (2020): 1708-1720.
  13. Lescure F-X., et al. “Clinical and virological data of the first cases of COVID-19 in Europe: a case series”. The Lancet Infectious Diseases6 (2020): 697-706.
  14. Daruich A., et al. “Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): Interest of telemedicine during the pandemic context”. Journal Francais D'Ophtalmologie5 (2020): 389-391.
  15. Deng C., et al. “Ocular Dectection of SARS-CoV-2 in 114 Cases of COVID-19 Pneumonia in Wuhan, China: An Observational Study”. SSRN Electronic Journal (2020).
  16. Loon SC., et al. “The severe acute respiratory syndrome coronavirus in tears”. The British Journal of Ophthalmology7 (2004): 861-863.
  17. Seah IYJ., et al. “Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients”. Ophthalmology7 (2020): 977-979.
  18. Xia J., et al. “Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection”. Journal of Medical Virology6 (2020): 589-594.
  19. Mela EK., et al. “Ocular surface bacterial colonisation in sedated intensive care unit patients”. Anaesthesia and Intensive Care1 (2010): 190-193.
  20. Saritas TB., et al. “Ocular surface disorders in intensive care unit patients”. Scientific World Journal (2013): 182038.
  21. Ohno S., et al. “Ocular manifestations of Kawasaki's disease (mucocutaneous lymph node syndrome)”. American Journal of Ophthalmology 6 (1982): 713-717.
  22. Wei H., et al. “The 2019 novel cornoavirus pneumonia with onset of oculomotor nerve palsy: a case study”. Journal of Neurology 5 (2020): 1550-1553.
  23. Marmor MF. “COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?” American Journal of Ophthalmology 213 (2020): A3-A4.
  24. Caress JB., et al. “COVID-19–associated Guillain-Barré syndrome: The early pandemic experience”. Muscle and Nerve (2020).
  25. Marinho PM., et al. “Retinal findings in patients with COVID-19”. The Lancet10237 (2020): 1610.
  26. Ouassou H., et al. “The Pathogenesis of Coronavirus Disease 2019 (COVID-19): Evaluation and Prevention”. Journal of Immunology Research (2020): 1357983.
  27. Zhang Y., et al. “Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19”. The New England Journal of Medicine 17 (2020): e38.
  28. Gautret P., et al. “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”. International Journal of Antimicrobial Agents1 (2020): 105949.
  29. Navajas EV., et al. “Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease”. Canadian Journal of Ophthalmology6 (2015): 442-450.
  30. Chen L., et al. “Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease”. British Journal of Ophthalmology 2 (2020): 748-751.
  31. Colavita F., et al. “SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection (2020): 242-243.
  32. Hong N., et al. “Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19”. Acta Ophthalmologica 5 (2020): e649-e655.
  33. Cheema M., et al. “Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19) (2020): e125-e129.
  34. Scalinci SZ and Trovato Battagliola E. “Conjunctivitis can be the only presenting sign and symptom of COVID-19 (2020): e00774.
  35. Loffredo L., et al. “Conjunctivitis and COVID-19: A meta-analysis”. Journal of Medical Virology 9 (2020): 1413-1414.
  36. Hernandez EV and Mannis MJ. “Superficial keratopathy in intensive care unit patients”. American Journal of Ophthalmology 2 (1997): 212-216.
  37. Gavriilaki E and Brodsky RA. “Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily”. British Journal of Haematology 6 (2020): e227-e230.
  38. Rasmussen KL., et al. “Complement C3 and Risk of Diabetic Microvascular Disease: A Cohort Study of 95202 Individuals from the General Population”. Clinical Chemistry 7 (2018): 1113-1124.
  39. Strain W and Chaturvedi N. “The renin-angiotensin-aldosterone system and the eye in diabetes”. Journal of the Renin-Angiotensin-Aldosterone System: JRAAS 3 (2003): 243-246.
  40. Gutiérrez-Ortiz C., et al. “Miller Fisher syndrome and polyneuritis cranialis in COVID-19”. Neurology5 (2020): e601-e605.
  41. Dinkin M., et al. “COVID-19 presenting with ophthalmoparesis from cranial nerve palsy”. Neurology 5 (2020): 221.
  42. Jones VG., et al. “COVID-19 and Kawasaki Disease: Novel Virus and Novel Case”. Hospital Pediatrics 6 (2020): 537-540.
  43. Abbas A and Hyman G. “Macular hemorrhage secondary to increased intrathoracic pressure and difficult intubation”. JPMA The Journal of the Pakistan Medical Association 52 (2002): 265-266.
  44. Kadayifcilar S., et al. “Ocular complications with high-dose interferon alpha in chronic active hepatitis”. Eye 3 (1999): 241-246.
  45. Schulman JA., et al. “Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin”. Ophthalmology 2 (2003): 437-442.
  46. Roe RH., et al. “Retinal pigment epitheliopathy, macular telangiectasis, and intraretinal crystal deposits in HIV-positive patients receiving ritonavir”. Retina3 (2011): 559-565.
  47. Tada A., et al. “Anti-interleukin-6 receptor antibody therapy-induced retinopathy in a patient with rheumatoid arthritis”. Case Reports in Rheumatology (2012): 270315.
Citation: Amna Saeed Fallata., et al. “Ocular Findings of Patients with Coronavirus Disease 2019 (COVID-19): A Literature Review”. EC Microbiology 17.1 (2021): 91-98.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


March Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the March issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for April Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the April issue of respective journals. Submissions are accepted on/before March 18, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk